Reduction in:-TNF-α production [71];-NF-κB and TGF-β levels in diabetic nephropathy [72];-TGF-β, VCAM-1, and NF-κB expression, and ROI’s production [73];-left ventricular hypertrophy and fibrosis [73]. This evidence concerns the gene TGFB1 and left ventricular hypertrophy.